Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2

BACKGROUND: Progressive pulmonary fibrosis is a serious complication in subjects with sarcoidosis. The absence of reliable, non-invasive biomarkers that detect early progression exacerbates the difficulty in predicting sarcoidosis severity. To potentially address this unmet need, we evaluated a pane...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Nancy G., Reyes-Hernon, Vivian, Gregory, Taylor, Sun, Belinda, Bermudez, Tadeo, Hufford, Matthew K., Oita, Radu C., Camp, Sara M., Hernandez-Molina, Gabriela, Serrano, Jorge Rojas, Sun, Xiaoguang, Fimbres, Jocelyn, Mirsaeidi, Mehdi, Sammani, Saad, Bime, Christian, Garcia, Joe G. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640603/
https://www.ncbi.nlm.nih.gov/pubmed/36388923
http://dx.doi.org/10.3389/fmed.2022.1012827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640603/
https://www.ncbi.nlm.nih.gov/pubmed/36388923
http://dx.doi.org/10.3389/fmed.2022.1012827

Ejemplares similares